AI Medical Compendium Topic

Explore the latest research on artificial intelligence and machine learning in medicine.

Drug Repositioning

Showing 211 to 220 of 257 articles

Clear Filters

Interpretable deep learning translation of GWAS and multi-omics findings to identify pathobiology and drug repurposing in Alzheimer's disease.

Cell reports
Translating human genetic findings (genome-wide association studies [GWAS]) to pathobiology and therapeutic discovery remains a major challenge for Alzheimer's disease (AD). We present a network topology-based deep learning framework to identify dise...

Deep learning identifies explainable reasoning paths of mechanism of action for drug repurposing from multilayer biological network.

Briefings in bioinformatics
The discovery and repurposing of drugs require a deep understanding of the mechanism of drug action (MODA). Existing computational methods mainly model MODA with the protein-protein interaction (PPI) network. However, the molecular interactions of dr...

A new framework for drug-disease association prediction combing light-gated message passing neural network and gated fusion mechanism.

Briefings in bioinformatics
With the development of research on the complex aetiology of many diseases, computational drug repositioning methodology has proven to be a shortcut to costly and inefficient traditional methods. Therefore, developing more promising computational met...

MHADTI: predicting drug-target interactions via multiview heterogeneous information network embedding with hierarchical attention mechanisms.

Briefings in bioinformatics
MOTIVATION: Discovering the drug-target interactions (DTIs) is a crucial step in drug development such as the identification of drug side effects and drug repositioning. Since identifying DTIs by web-biological experiments is time-consuming and costl...

A geometric deep learning framework for drug repositioning over heterogeneous information networks.

Briefings in bioinformatics
Drug repositioning (DR) is a promising strategy to discover new indicators of approved drugs with artificial intelligence techniques, thus improving traditional drug discovery and development. However, most of DR computational methods fall short of t...

AttentionSiteDTI: an interpretable graph-based model for drug-target interaction prediction using NLP sentence-level relation classification.

Briefings in bioinformatics
In this study, we introduce an interpretable graph-based deep learning prediction model, AttentionSiteDTI, which utilizes protein binding sites along with a self-attention mechanism to address the problem of drug-target interaction prediction. Our pr...

Contexts and contradictions: a roadmap for computational drug repurposing with knowledge inference.

Briefings in bioinformatics
The cost of drug development continues to rise and may be prohibitive in cases of unmet clinical need, particularly for rare diseases. Artificial intelligence-based methods are promising in their potential to discover new treatment options. The task ...

Mitigating cold-start problems in drug-target affinity prediction with interaction knowledge transferring.

Briefings in bioinformatics
Predicting the drug-target interaction is crucial for drug discovery as well as drug repurposing. Machine learning is commonly used in drug-target affinity (DTA) problem. However, the machine learning model faces the cold-start problem where the mode...

D3AI-CoV: a deep learning platform for predicting drug targets and for virtual screening against COVID-19.

Briefings in bioinformatics
Target prediction and virtual screening are two powerful tools of computer-aided drug design. Target identification is of great significance for hit discovery, lead optimization, drug repurposing and elucidation of the mechanism. Virtual screening ca...

DTI-HETA: prediction of drug-target interactions based on GCN and GAT on heterogeneous graph.

Briefings in bioinformatics
Drug-target interaction (DTI) prediction plays an important role in drug repositioning, drug discovery and drug design. However, due to the large size of the chemical and genomic spaces and the complex interactions between drugs and targets, experime...